SEARCH

SEARCH BY CITATION

References

  • 1
    Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen and convulxin. Blood 2000; 95: 1694702.
  • 2
    Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002; 415: 1759.
  • 3
    Szasz R, Dale GL. COAT-platelets. Curr Opin Hematol 2003; 10: 3515.
  • 4
    Remenyi G, Szasz R, Friese P, Dale GL. Role of mitochondrial permeability transition pore in coated-platelet formation. Arterioscler Thromb Vasc Biol 2005; 25: 46771.
  • 5
    Dale GL. Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost 2005; in press.
  • 6
    Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 1820512.
  • 7
    Yano Y, Kambayashi J-I, Shiba E, Sakon M, Oiki E, Fukuda K, Kawasaki T, Mori T. The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. Biochem J 1994; 299: 3038.
  • 8
    Holme PA, Roger M, Solum NO, Brosstad F, Larsen AM, Hovig T. Glycoprotein IIb-IIIa on platelet derived microparticles, and microparticle structures studies by electron microscopy, confocal laser microscopy and crossed radio-immunoelectrophoresis. Platelets 2004; 7: 20714.
  • 9
    Tocchetti EV, Flower RL, Lloyd JV. Assessment of in vitro-generated platelet microparticles using a modified flow cytometric strategy. Thromb Res 2001; 103: 4755.
  • 10
    Freyssinet JM. Cellular microparticles: what are they bad or good for? J Thromb Haemost 2003; 1: 165562.
  • 11
    VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59: 27787.
  • 12
    Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004; 34: 392401.
  • 13
    Jy W, Horstman JJ, Ahn YS. Forum: measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 184251.
  • 14
    Batar P, Dale GL. Simultaneous engagement of thrombin and Fc-gamma-RIIA receptors results in platelets expressing high levels of procoagulant proteins. J Lab Clin Med 2001; 138: 393402.
  • 15
    Holme PA, Solum NO, Brosstad F, Roger M, Abdelnoor M. Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting. Thromb Haemost 1994; 72: 66671.
  • 16
    Heijnen HFG, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and α-granules. Blood 1999; 94: 37919.
  • 17
    Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, ten Have K, Eijsman L, Hack CE, Sturk A. Cell derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997; 96: 353441.
  • 18
    Pasquet JM, Dachary-Prigent J, Nurden AT. Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen. Biochem J 1998; 333: 5919.
  • 19
    Parise LV, Smyth SS, Coller BS. Platelet morphology, biochemistry and function. In: BeutlerE, LichtmanMA, CollerBS, KippsTJ, SeligsohnU, eds.Williams Hematology. New York: McGraw-Hill, 2001: 1357408.